Bortezomib, Thalidomide, and Dexamethasone (Vtd) Versus Vtd Plus Cyclophosphamide as Induction Therapy in Previously Untreated Multiple Myeloma Patients Eligible for Hdt-Asct: A Randomized Phase 2 Trial.

AuthID
 P-003-EAH
13
Author(s)
Ludwig, H
·
Greil, R
·
Spicka, I
·
Shpilberg, O
·
Hajek, R
·
Dmoszynska, A
·
Cakana, A
·
Enny, C
·
Feng, HB
·
van de Velde, H
·
Harousseau, JL
Document Type
Abstract
Year published
2009
Published
in BLOOD, ISSN: 0006-4971
Volume: 114, Issue: 22, Pages: 913-914 (2)
Conference
51St Annual Meeting of the American-Society-Of-Hematology, Date: DEC 05-08, 2009, Location: New Orleans, LA, Sponsors: Amer Soc Hematol
Indexing
Wos®
Publication Identifiers
Wos: WOS:000272725802680
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas instituições

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service